Insulin Aspart price in Malaysia (2026)
Bangladesh list prices converted into MYR, plus the registration rules of the NPRA, the legal import routes and the real cost build-up for Malaysia.
Currency conversion
| Item | BDT | MYR | USD |
|---|
Bangladesh benchmark (world reference price)
Registered brands and list prices for this molecule in Bangladesh (DGDA registration, via MedEx).
| Brand | Manufacturer | Strength | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Glyset Mix | Incepta Pharmaceuticals Ltd. | 100 IU/ml SC Injection | — | — | — |
| Rapilog | Square Pharmaceuticals PLC | 100 IU/ml SC Injection | — | — | — |
| Fiasp FlexTouch Originator | Novo Nordisk Pharma (Pvt.) Ltd | 100 IU/ml SC Injection | — | — | 5's pack: ৳ 4,750.00 |
Source: MedEx Bangladesh drug registry (list prices of DGDA-registered brands). Unit prices move with pack size, pharmacy and exchange rate — reference only. Original registry page
Import and regulatory notes
National Pharmaceutical Regulatory Agency (NPRA). Malaysia has one of the better-regulated generics markets in ASEAN: products must be registered with the NPRA with a valid product licence, and hospital procurement runs through government tenders. Patient-level imports of unregistered products require an NPRA import authorisation.
How to obtain it legally
- Obtain a prescription plus the diagnostic/genetic report from the treating physician (e.g. the target-mutation result).
- Confirm the exact brand and strength, and ask the supplier for the batch number, certificate of analysis (COA) and the manufacturer's GMP credentials.
- Clear the shipment through a NPRA-licensed importer or pharmacy; unregistered products go through the named-patient route.
- Check batch number, expiry and packaging on arrival, then follow the prescriber's monitoring schedule.
What adds to the price when you import
- International freight and cold chain (monoclonal antibodies and insulins need 2–8°C end-to-end).
- Customs duty and import VAT in Malaysia.
- Compliance, licensing and warehousing cost of the importer/distributor (typically 10–30%).
- Order size and pack configuration — full cases price below retail strips.
- Exchange-rate movement: this page converts at 1 USD = 122.87 BDT.
Availability in Southeast Asia
| Country | Status | Notes |
|---|---|---|
| Malaysia | available | Gan & Lee's fast-acting insulin aspart cartridge received marketing approval from Malaysia's NPRA (announced June 2025), completing registration of basal, fast-acting and premixed insulin analogs in the country after approvals for insulin glargine (February 2025) and insulin aspart 30 (March 2025). |
Frequently asked questions
How much does insulin aspart cost in Malaysia?
No published price data recorded for this molecule.
Can I legally import insulin aspart into Malaysia?
Yes, but only through the rules of the National Pharmaceutical Regulatory Agency (NPRA): Malaysia has one of the better-regulated generics markets in ASEAN: products must be registered with the NPRA with a valid product licence, and hospital procurement runs through government tenders. Patient-level imports of unregistered products require an NPRA import authorisation. Prescription medicines must move on a valid prescription through a licensed importer, pharmacy or hospital; personal-use imports need a named-patient / compassionate-use authorisation.
Are Bangladeshi or Indian generics of insulin aspart approved in Malaysia?
We cannot confirm the registration status of every individual generic brand in Malaysia. National Pharmaceutical Regulatory Agency (NPRA) is the approving authority, and only products with a local product registration (or a special import authorisation) may be sold routinely. Ask your supplier for the local registration or import permit for the specific brand before you buy.
Why is the Bangladesh price a useful reference?
Bangladesh is a least-developed-country WTO member with a pharmaceutical patent exemption running to 2033, so local manufacturers can legally produce molecules that are still on patent elsewhere — and DGDA-registered list prices are public. That makes it the practical global floor price for on-patent targeted therapy and the benchmark used in import negotiations.
What is the availability situation for insulin aspart in Malaysia?
Malaysia: available. Gan & Lee's fast-acting insulin aspart cartridge received marketing approval from Malaysia's NPRA (announced June 2025), completing registration of basal, fast-acting and premixed insulin analogs in the country after approvals for insulin glargine (February 2025) and insulin aspart 30 (March 2025).
This molecule in other markets
This page is an information resource for healthcare professionals, licensed importers and patients under medical care. It is not medical advice, not a prescription service, and not an offer to sell prescription medicines to the public.
Also sourced for Malaysia
Need a verified quotation?
Send us the molecule, strength, pack size, quantity and destination country. We reply with a batch-traceable quotation, certificates of analysis and shipping documentation.
We supply licensed pharmacies, hospitals, importers and distributors — not direct-to-consumer patients.